Inhaled Nitric Oxide Treatment of Early Pulmonary Hypertension to Reduce the Risk of Death or Bronchopulmonary Dysplasia in Infants Born Extremely Preterm: A Masked Randomized Controlled Trial

Inhaled Nitric Oxide Treatment of Early Pulmonary Hypertension to Reduce the Risk of Death or Bronchopulmonary Dysplasia in Infants Born Extremely Preterm: A Masked Randomized Controlled Trial

To determine whether inhaled nitric oxide (iNO) treatment of early pulmonary hypertension (PH) would decrease the risk of death or bronchopulmonary dysplasia (BPD) among infants born extremely preterm. This was a single-center, masked, randomized controlled trial involving infants born at

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pediatrics 2024-12, Vol.278, p.114427, Article 114427
Hauptverfasser: Mirza, Hussnain, Garcia, Jorge, Zussman, Matthew, Wadhawan, Rajan, Pepe, Julie, Oh, William
Format: Artikel
Sprache:eng
Schlagworte:
Bronchopulmonary Dysplasia
delayed pulmonary vascular transition
early pulmonary hypertension
Inhaled Nitric Oxide
Preterm Infants
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To determine whether inhaled nitric oxide (iNO) treatment of early pulmonary hypertension (PH) would decrease the risk of death or bronchopulmonary dysplasia (BPD) among infants born extremely preterm. This was a single-center, masked, randomized controlled trial involving infants born at
ISSN:0022-3476
1097-6833
1097-6833
DOI:10.1016/j.jpeds.2024.114427